AIM ImmunoTech Inc (NYSE American:AIM)

0.9205
Delayed Data
As of May 27
 +0.0005 / +0.05%
Today’s Change
0.55
Today|||52-Week Range
2.40
+0.05%
Year-to-Date
No recent news for AIM ImmunoTech Inc.

Today’s Trading

Previous close0.92
Today’s open0.92
Day’s range0.90 - 0.92
Volume87,644
Average volume (3 months)427,006
Market cap$47.6M
Data as of 3:59pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)+10.66%
Earnings growth (this year)+18.33%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-17.18%
P/E ratioNM
Price/Sales322.61
Price/Book0.85

Competitors

 Today’s
change
Today’s
% change
BYSIBeyondspring Inc+0.17+15.04%
AGTCApplied Genetic Tech...-0.02-2.72%
ZYNEZynerba Pharmaceutic...+0.01+0.73%
APMAptorum Group Ltd+0.05+4.10%
Data as of 3:59pm ET, 05/27/2022

Financials

Next reporting dateAugust 16, 2022
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$135.0K
Annual profit (last year)-$19.1M
Net profit margin-14,168.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Ocala, Florida

Forecasts